By Staff Reporter A 49-year-old medical doctor based in Gweru appeared before the Gweru Magistrates’ Court for possession and alleged use of crystal meth, locally known as mutoriro. Dr. Farikayi Manjeya, a specialist obstetrician and gynaecologist was charged alongside Tafara Chigoya (28), Kudakwashe Godknows Mutata (29), and Tariro Pambwa (35). Police, according to the
Read More
As has become tradition at HealthTimes, every year we honour leaders in the healthcare sector who are making a difference and contributing significantly to Zimbabwe’s health system. This year, we are doing things differently. We have categorised the champions according to their sectors or areas of influence, focusing on innovation and the strategies that healthcare leaders in Zimbabwe
Read MoreBy Kuda Pembere As Zimbabwe transitions into the second phases of the National Development Strategy (NDS2) and the National Health Strategy (NHS2), Health and Child Care Minister Dr Douglas Mombeshora says the government has identified six priority areas to build a resilient, equitable, and high-performing public health system. Officiating at the Health Ministry’s Strategic Review
Read MoreAs has become tradition at HealthTimes, every year we honour leaders in the healthcare sector who are making a difference and contributing significantly to Zimbabwe’s health system. This year, we are doing things differently. We have categorised the champions according to their sectors or areas of influence, focusing on innovation and the strategies that healthcare
Read More
Vilon, a synthetic dipeptide composed of lysine and glutamic acid (Lys-Glu), has emerged as a molecule of growing interest in the field of bioregulatory peptide research. Despite its minimal structure, Vilon is theorized to exert a wide range of biological supports, particularly in the domains of immunomodulation, gene expression regulation, and cellular aging. Originally developed
Read MoreVilon, a synthetic dipeptide composed of lysine and glutamic acid (Lys-Glu), has emerged as a molecule of growing interest in the field of bioregulatory peptide research. Despite its minimal structure, Vilon is theorized to exert a wide range of biological supports, particularly in the domains of immunomodulation, gene expression regulation, and cellular aging. Originally developed
Read More